Name: Fristamin 10mg Loratadine,7
Brand: Fristamin
SKU: Shjetppharm4
Availability: InStock

Fristamin 10mg Loratadine,7

€6.45

allergic rhinitis-Fristamin 10mg Loratadine,7

20 People watching this product now!

INDICATIONS
Symptomatic treatment of allergic rhinitis and chronic idiopathic urticaria.
CONTRAINDICATIONS / SECONDARY EFFECT
Hypersensitivity ‘to the active substance or to any of the listed excipients.
DOSAGE
Adults: one tablet once a day. Children aged 6 years and over weighing more than 30 kg: one tablet once a day. For an appropriate dosage for children aged less than 6 years or weighing 30 kg or less there are other more suitable formulations. Children younger than 2 years: the safety and efficacy of the medicine have not been established. No data are available. Patients with hepatic impairment: Patients with severe hepatic impairment should be given a lower starting dose as they may have reduced clearance of loratadine. A starting dose of 10 mg every other day is recommended for adults and children weighing more than 30 kg. Patients with renal impairment: No dosage adjustments are required in patients with renal insufficiency. Elderly: No dosage adjustments are required. Method of administration: oral use. The tablet can be taken regardless of mealtimes.
STORAGE
This medicine does not require any special storage conditions.
WARNINGS
The drug should be administered with caution in patients with severe hepatic impairment. This medicine contains lactose; therefore patients with rare hereditary problems of galactose intolerance, the Lapp syndrome due to lactase deficiency or glucose-galactose malabsorption should not take this medicinal product. The administration of the medicinal product must be interrupted at least 48 hours before skin tests as antihistamines can prevent or reduce the positive reactions to the skin reactivity indices.
INTERACTIONS
Concomitant intake of the drug with alcohol does not potentiate its effects, as assessed by psychophysical performance studies. Potential interactions with all known inhibitors of CYP3A4 and CYP2D6 can occur resulting in elevated loratadine levels, which can lead to increased adverse events. Increased plasma concentrations of loratadine have been reported after concomitant use with ketoconazole, erythromycin and cimetidine in controlled clinical trials, but with no clinically significant changes (including electrocardiographic changes). Pediatric population: Interaction studies have only been performed in adults.